Middle-aged and older adults with torn cartilage or painful arthritis in their knee are not likely to benefit from so-called arthroscopic surgery, and could be harmed by it, a review […]

DUBLIN, IRELAND–(Marketwired – Jul 6, 2015) – Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines […]

Egalet Corp said data showed its experimental painkiller was less likely to be abused than a form of morphine already being sold. A study showed recreational opioid users did not […]

Spinifex Pharmaceuticals to be Acquired by Novartis STAMFORD, Connecticut and MELBOURNE, Australia, June 29, 2015 /PRNewswire/ —   US$200 million upfront payment plus undisclosed clinical development and regulatory milestones Expands […]

An experimental bladder pain syndrome/ interstitial cystitis drug being developed by immuno-oncology drugmaker Aquinox Pharmaceuticals, Inc. (AQXP) failed to meet its statistical endpoint during a mid-stage clinical trial, the company […]

Moderate- or high-quality evidence supports the use of marijuana for some medical conditions, but not for others, according to a fresh review of past research. After reviewing 80 randomized trials […]

Designed to prevent users from overdosing, abuse-deterrent opioids aim to diminish the effects of today’s epidemic by limiting the ways addicts can alter prescription painkillers for their needs. These drugs, subject […]

  Novartis AG said one-year results of its drug secukinumab show it is effective in treating patients with ankylosing spondylitis (AS), a debilitating joint condition of the spine.   The […]